Cargando…
Unapproved clinical trials in Russia: exception or norm?
BACKGROUND: In modern Russia, any clinical investigation of a pharmaceutical for use in humans is subject to prior evaluation and approval by the Ministry of Health and its Central Ethics Committee. Despite this, some researchers and trial sponsors fail to comply, this is particularly true in case o...
Autores principales: | Talantov, Petr, Niyazov, Ravil, Viryasova, Galina, Dranitsyna, Margarita, Yasny, Ilya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056644/ https://www.ncbi.nlm.nih.gov/pubmed/33879151 http://dx.doi.org/10.1186/s12910-021-00617-3 |
Ejemplares similares
-
Microbiological contamination in counterfeit and unapproved drugs
por: Pullirsch, Dieter, et al.
Publicado: (2014) -
Intercurrent events in clinical research: the norm, not the exception
por: Rojas-Saunero, L. Paloma, et al.
Publicado: (2022) -
The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs
por: Kesselheim, Aaron S., et al.
Publicado: (2012) -
Concerns about unapproved meningococcal vaccination for eculizumab therapy in Japan
por: Tanimoto, Tetsuya, et al.
Publicado: (2014) -
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication.
por: Galil, K, et al.
Publicado: (1999)